Novavax (NVAX) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Novavax (NVAX) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 10 | Novavax | 1.67 Bn | 953.49 Mn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.12% |
| Mar 31, 2026 | -26.16% |
| Dec 31, 2025 | -24.28% |
| Sep 30, 2025 | -17.92% |
| Jun 30, 2025 | 2.36% |
| Mar 31, 2025 | 65.38% |
| Dec 31, 2024 | 64.63% |
| Sep 30, 2024 | 87.76% |
| Jun 30, 2024 | 85.93% |
| Mar 31, 2024 | 60.93% |
| Dec 31, 2023 | 60.82% |
| Sep 30, 2023 | 59.30% |
| Jun 30, 2023 | 57.62% |
| Mar 31, 2023 | 56.81% |
| Dec 31, 2022 | 52.23% |
| Sep 30, 2022 | 46.94% |
| Jun 30, 2022 | 45.88% |
| Mar 31, 2022 | 44.35% |
| Dec 31, 2021 | 41.22% |
| Sep 30, 2021 | 39.29% |